Regenstrief Institute hires epidemiology, research expert as CEO
Dr. Rachel Patzer, director of the Health Services Research Center at the Emory University School of Medicine in Atlanta, will join Regenstrief Institute on May 1.
Medical school
-
IU med school shuts down research project that used expired supplies on pigs
Fred Cate, IU’s vice president for research, informed federal officials that the research group had “a pattern of non-compliance” and had been warned several times against using expired materials.
Read More -
IU medical school lands $1.25M for increasing diversity
The money will be used to provide new opportunities for graduate students typically underrepresented in biomedical science, officials said.
Read More -
Design approved for Indiana University’s new School of Medicine building
IU said the 11-story, 325,000-square-foot facility in Indianapolis will be used to address instructional and research needs of programs in the university’s school of medicine.
Read More -
Ballyhooed Simon Cancer Center to empty out by 2026
Just 12 years after opening to great fanfare, the future of the $150 million center, a partnership between the Indiana University School of Medicine and Indiana University Health, is full of questions.
Read More
Articles
Global-health group aims to launch new med school
The not-for-profit Tumaini Foundation for Global Health and Humanitarianism says it wants to train medical students with a special concern for the health of needy individuals and populations worldwide.
IU researchers developing virtual-reality tool to treat substance abuse
The high-tech approach allows a patient recovering from substance abuse to interact with potential future versions of himself or herself.
IU School of Medicine gets $12.5M gift commitment from Vera Bradley Foundation
The medical school said the commitment will help launch research efforts to develop better therapies for triple negative breast cancer, an aggressive form of breast cancer that is often not responsive to hormone therapies and is resistant to chemotherapy.
Initiative aims to spur innovation by connecting, analyzing data bases
Fueled with a $36 million Lilly Endowment Inc. grant, the Central Indiana Corporate Partnership has launched AnalytiXIN to promote innovations in data science throughout Indiana.
Indiana life science players have adapted to pandemic, panelists say
Speakers at the IBJ Life Sciences Power Panel on Friday said their organizations have largely weathered the lockdown—raising records funds, taking on huge expansions, hiring new employees and reporting higher productivity.
IU medical school to move, expand Family Medicine Center as part of campus consolidation
The center, which is home to one of the medical school’s largest programs, will move from its current location at Senate Avenue and 15th Street to the IUPUI campus.
Indy Beacons: Dr. William Wishard, hospital and nursing-school founder
In 1879, Dr. William N. Wishard, then 27 years old, became superintendent of Indianapolis City Hospital, an institution so little regarded that it lacked city water and gas.
IU medical school gears up for move to expanded Methodist Hospital campus
The move will uproot much of the medical school traditional operations. All classroom instruction for medical students will go to the new campus, as will graduate training programs in the clinical sciences for residents and fellows.
Coronavirus vaccine trial resumes after week-long pause
Some of the vaccine trials in the United States are taking place at Indiana University School of Medicine in Indianapolis.
IU cancer center researchers land $5.7M grant to study chemo-induced side effects
The grant will help fund an ongoing study to evaluate long-term health outcomes for cancer patients who receive life-saving chemotherapy treatments that often have difficult side effects.
Startup claims breakthrough in gauging pain
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
IBJ Podcast: This IU pediatrician is a health care myth buster
Should you avoid red meat? No. Should you strive for 10,000 steps a day? Not unless you just want to. So says Dr. Aaron Carroll, a pediatrician and researcher at the Indiana University School of Medicine who sees it as his life’s calling to debunk what he considers health myths and weak medical research.
IU medical school part of genomics research
The trials, which will begin in 2020, are part of a sweeping, five-year, $42 million federal research program known as Implementing Genomics in Practice. The first trial will examine whether early access to patients’ genomic data can help with treatment of high blood pressure, hypertension and chronic kidney disease.
IU researcher wins $44.7M to study rare form of Alzheimer’s disease
The IU School of Medicine said the grant, its largest-ever National Institutes of Health award, will fund a five-year study of a form of Alzheimer’s disease that affects young people.
IU School of Medicine leader finalist for new job in Oregon
Dr. Jay Hess is one of three finalists to become president at Oregon Health & Science University in Portland, according to The Oregonian.
Evansville medical campus expected to open in August
The facility will host students from Indiana University, University of Southern Indiana and University of Evansville.
IU Med School raises $135M in NIH funding for 2017, setting record
The funds includes $7.6 million to study early-onset Alzheimer’s disease, $5.2 million to fund a clinical and translational sciences institute, and $4.8 million to fund epidemiologic databases to evaluate AIDS care in Africa.
IU wins lawsuit by fired director accused of sexual harassment
A district court judge ruled Indiana University’s School of Dentistry and high-ranking members of its faculty did not violate a former clinic director’s rights by firing him for alleged sexual harassment of students.
IU, Purdue get $2.55M to study breast cancer
Researchers at Indiana University and Purdue University have received $2.55 million from Susan G. Komen to study possible new treatments.